{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:39:15Z","timestamp":1794379155120,"version":"4.9.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["CP15\/00158"],"award-info":[{"award-number":["CP15\/00158"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI15\/0133"],"award-info":[{"award-number":["PI15\/0133"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PI17\/01316"],"award-info":[{"award-number":["PI17\/01316"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["RD16\/0012\/0015"],"award-info":[{"award-number":["RD16\/0012\/0015"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-7940"],"award-info":[{"award-number":["CTS-7940"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0191-2013"],"award-info":[{"award-number":["PI-0191-2013"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.autrev.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:45:12Z","timestamp":1536684312000},"page":"1138-1149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets"],"prefix":"10.1016","volume":"17","author":[{"given":"Irene","family":"Cecchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Arias de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Roccatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Collantes-Estevez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chary","family":"Lopez-Pedrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Barbarroja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.06.006_bb0005","first-page":"551","article-title":"One year in review: the pathogenesis of rheumatoid arthritis","volume":"33","author":"Picerno","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.rdc.2010.03.003","article-title":"Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention","volume":"36","author":"Karmakar","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2018.06.006_bb0015","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.06.006_bb0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","article-title":"Crosstalk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2567.2006.02424.x","article-title":"Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis","volume":"119","author":"Tanaka","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2018.06.006_bb0030","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.39117","article-title":"CCR2 expression in neutrophils plays a critical role in their migration into the joints in rheumatoid arthritis","volume":"67","author":"Talbot","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0035","doi-asserted-by":"crossref","first-page":"E3177","DOI":"10.1073\/pnas.1213797109","article-title":"Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and Fc R signaling","volume":"109","author":"Sadik","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2018.06.006_bb0040","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar4377","article-title":"Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis","volume":"15","author":"Zhu","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0045","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.06.006_bb0050","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2006-03-013771","article-title":"The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages","volume":"109","author":"Dzhagalov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0055","first-page":"1990","article-title":"Leukotriene B(4) inhibits neutrophil apoptosis via NADPH oxidase activity: redox control of NF-\u03baB pathway and mitochondrial stability","volume":"2012","author":"Barcellos-De-Souza","year":"1823","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2018.06.006_bb0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1189\/jlb.0306178","article-title":"Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints","volume":"80","author":"Cross","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0065","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1161\/ATVBAHA.114.304475","article-title":"Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis","volume":"34","author":"Barbarroja","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0070","first-page":"39","article-title":"Neutrophils produce interleukin-17B in rheumatoid synovial tissue","volume":"53","author":"Kouri","year":"2014","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.autrev.2018.06.006_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13075-015-0759-2","article-title":"Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1\u03b2 production","volume":"17","author":"Pinto","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cyto.2017.06.009","article-title":"Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis","volume":"97","author":"\u0160enolt","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2018.06.006_bb0085","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/art.22697","article-title":"Tumor necrosis factor \u03b1 activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint","volume":"56","author":"Assi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.05.002","article-title":"Myeloperoxidase: a new player in autoimmunity","volume":"317","author":"Strzepa","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0095","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1182\/blood-2012-09-456483","article-title":"Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function","volume":"121","author":"Odobasic","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.38299","article-title":"Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis","volume":"66","author":"Odobasic","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00296-011-1810-5","article-title":"Increased myeloperoxidase plasma levels in rheumatoid arthritis","volume":"32","author":"Fernandes","year":"2012","journal-title":"Rheumatol Int"},{"issue":"296","key":"10.1016\/j.autrev.2018.06.006_bb0110","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1126\/science.1106830","article-title":"Myeloperoxidase, a leukocyte-derived vascular NO oxidase","volume":"80","author":"Eiserich","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2018.06.006_bb0115","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2010-05-284513","article-title":"Myeloperoxidase attracts neutrophils by physical forces","volume":"117","author":"Klinke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/oxfordjournals.jbchem.a123277","article-title":"Human neutrophil elastase: degradation of basement membrane components and immunolocalization in the tissue","volume":"108","author":"Watanabe","year":"1990","journal-title":"J Biochem"},{"key":"10.1016\/j.autrev.2018.06.006_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/art.22312","article-title":"Evaluation of protease-activated receptor 2 in murine models of arthritis","volume":"56","author":"Busso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0135","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bph.13237","article-title":"Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2","volume":"173","author":"Muley","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"NADPH oxidases: an overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3858\/emm.2009.41.4.058","article-title":"p47phox, the phagocyte NADPH oxidase\/NOX2 organizer: structure, phosphorylation and implication in diseases","volume":"41","author":"El-Benna","year":"2009","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","article-title":"Novel cell death program leads to neutrophil extracellular traps","volume":"176","author":"Fuchs","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0155","series-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review","author":"Lee","year":"2017"},{"key":"10.1016\/j.autrev.2018.06.006_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00485","article-title":"NETosis as source of autoantigens in rheumatoid arthritis","volume":"7","author":"Corsiero","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0165","article-title":"RA_ACPA_NETs_SciTranMed2013","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0170","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","article-title":"Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility","volume":"16","author":"Sur Chowdhury","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2017.04.007","article-title":"Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients","volume":"82","author":"P\u00e9rez-S\u00e1nchez","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.06.006_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2015.04.004","article-title":"Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference","volume":"14","author":"Bonanni","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.06.006_bb0185","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.smim.2016.03.004","article-title":"Human neutrophils in auto-immunity","volume":"28","author":"Thieblemont","year":"2016","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0195","first-page":"616","article-title":"Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential","volume":"12","author":"Jones","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.autrev.2018.06.006_bb0200","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/art.39313","article-title":"Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid","volume":"67","author":"Spengler","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","article-title":"Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation","volume":"183","author":"Ruiz-Lim\u00f3n","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.autrev.2018.06.006_bb0215","first-page":"11","article-title":"Advances in the medical treatment of rheumatoid arthritis","volume":"27","author":"Michelle","year":"2011","journal-title":"NIH Public Access"},{"issue":"15 Suppl. 3","key":"10.1016\/j.autrev.2018.06.006_bb0220","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","author":"Crofford","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0225","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.06.006_bb0230","series-title":"Kelley's Textbook of Rheumatology. Crofford L: Prostanoid biology and its therapeutic targeting","article-title":"Prostanoid biology and its therapeutic targeting","author":"Crofford","year":"2013"},{"key":"10.1016\/j.autrev.2018.06.006_bb0235","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.1780391208","article-title":"Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation","volume":"39","author":"Mahmud","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0240","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1073\/pnas.92.17.7926","article-title":"The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase","volume":"92","author":"Amin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.06.006_bb0245","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.autrev.2018.06.006_bb0250","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI117853","article-title":"Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs","volume":"95","author":"D\u00edaz-Gonz\u00e1lez","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.06.006_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-5699(97)01216-4","article-title":"Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs","volume":"19","author":"D\u00edaz-Gonz\u00e1lez","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2018.06.006_bb0260","doi-asserted-by":"crossref","first-page":"38212","DOI":"10.1074\/jbc.M205142200","article-title":"Structure-function relationship and role of tumor necrosis factor-\u03b1-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs","volume":"277","author":"G\u00f3mez-Gaviro","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2018.06.006_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/eji.201242805","article-title":"In vivo modulation of the inflammatory response by nonsteroidal antiinflammatory drug-related compounds that trigger L -selectin shedding","volume":"43","author":"Herrera-Garc\u00eda","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0270","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","article-title":"Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion","volume":"95","author":"Pillinger","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.06.006_bb0275","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/bph.12670","article-title":"Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways","volume":"171","author":"Bertolotto","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-2952(84)90228-4","article-title":"Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo","volume":"33","author":"Kaplan","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.1997.501-ce1400.x","article-title":"Chemoattractant-induced release of elastase by lipopolysaccharide (LPS)-primed neutrophils; inhibitory effect of the anti-inflammatory drug nimesulide","volume":"110","author":"Ottonello","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0290","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4049\/jimmunol.176.2.957","article-title":"Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1","volume":"176","author":"Derouet","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0295","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.112.202879","article-title":"Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs","volume":"345","author":"Lapponi","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0300","first-page":"67","article-title":"Long-term adverse events after daily concomitant treatment with 10\u202fmg prednisone in the 2-year computer assisted management in early rheumatoid arthritis trial-II","author":"de Hair","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0305","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.CIR.98.21.2307","article-title":"Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes","volume":"98","author":"Nakagawa","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2018.06.006_bb0310","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00918958","article-title":"Induction of neutrophil infiltration by rat chemotactic cytokine (CINC) and its inhibition by dexamethasone in rats","volume":"16","author":"Hirasawa","year":"1992","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2018.06.006_bb0315","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0165-2427(93)90065-C","article-title":"Effects of in vitro adrenocorticotrophic hormone, cortisol and human recombinant interleukin-2 on porcine neutrophil migration and luminol-dependent chemiluminescence","volume":"39","author":"Salak","year":"1993","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/thx.49.3.207","article-title":"Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro","volume":"49","author":"Llewellyn-Jones","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2018.06.006_bb0325","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0024-3205(97)00290-7","article-title":"Methylprednisolone inhibits neutrophil-endothelial cell interactions induced by interleukin-1beta under flow conditions","volume":"60","author":"Yoshida","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2018.06.006_bb0330","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-3565(25)22251-0","article-title":"An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils","volume":"250","author":"Schleimer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0335","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/01.CIR.96.1.295","article-title":"Glucocorticoid receptor regulates expression of L-selectin and CD11\/CD18 on human neutrophils","volume":"96","author":"Filep","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2018.06.006_bb0340","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/BF03547793","article-title":"The effect of prednisolone on canine neutrophil function: in vivo and in vitro studies","volume":"39","author":"Trowald-Wigh","year":"1998","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.autrev.2018.06.006_bb0345","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jlb.61.2.224","article-title":"Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis","volume":"61","author":"Cox","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(98)00426-9","article-title":"Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats","volume":"354","author":"Nittoh","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0355","first-page":"128","article-title":"In vivo effect of methylprednisolone on lipopolysaccharide-induced superoxide production by pulmonary and circulating blood neutrophils in rats","volume":"42","author":"Tsuji","year":"1994","journal-title":"Circ Shock"},{"key":"10.1016\/j.autrev.2018.06.006_bb0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1019714618068","article-title":"Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species","volume":"26","author":"Ruiz","year":"2002","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2018.06.006_bb0365","first-page":"2065","article-title":"Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype","volume":"22","author":"Youssef","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0370","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.1780390207","article-title":"Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone","volume":"39","author":"Youssef","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0375","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/art.1780391205","article-title":"Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression","volume":"39","author":"Youssef","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0380","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0385","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/annrheumdis-2016-210711","article-title":"Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Chatzidionysiou","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.06.006_bb0390","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/eci.11.20","article-title":"Leflunomide in renal transplantation","volume":"7","author":"Chon","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0395","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/petr.12029","article-title":"Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation","volume":"17","author":"Jung","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.autrev.2018.06.006_bb0400","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/imt.10.52","article-title":"Leflunomide: a drug with a potential beyond rheumatology","volume":"2","author":"Teschner","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.autrev.2018.06.006_bb0405","doi-asserted-by":"crossref","first-page":"44266","DOI":"10.18632\/oncotarget.17863","article-title":"Leflunomide\/teriflunomide inhibit Epstein-barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication","volume":"8","author":"Bilger","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.autrev.2018.06.006_bb0410","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-3565(25)24292-6","article-title":"The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism","volume":"272","author":"Cherwinski","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0415","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0006-2952(99)00228-2","article-title":"In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action","volume":"58","author":"Xu","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00192310","article-title":"Effects of leflunomide on immune responses and models of inflammation","volume":"14","author":"Bartlett","year":"1993","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0425","series-title":"Differential effects of leflunomide on leukocytes: inhibition of rat in vivo adhesion and human in vitro oxidative burst without affecting surface marker modulation","first-page":"276","volume":"278","author":"Zielinski","year":"1994"},{"key":"10.1016\/j.autrev.2018.06.006_bb0430","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/art.10712","article-title":"Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68","volume":"48","author":"Montesinos","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0435","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.4049\/jimmunol.167.5.2911","article-title":"Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation","volume":"167","author":"Majumdar","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0440","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.06.006_bb0445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00541349","article-title":"Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients","volume":"8","author":"O'Callaghan","year":"1988","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.06.006_bb0450","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1529-0131(200007)43:7<1488::AID-ANR11>3.0.CO;2-G","article-title":"Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients","volume":"43","author":"Kraan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0455","first-page":"885","article-title":"Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy","volume":"25","author":"Weinmann","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0460","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2002.tb04219.x","article-title":"Delayed neutrophil apoptosis induced by synovial fluid in rheumatoid arthritis: role of cytokines, estrogens, and adenosine","volume":"966","author":"Ottonello","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2018.06.006_bb0465","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2009","article-title":"Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis","volume":"8","author":"Raza","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0470","first-page":"2092","article-title":"Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits","volume":"23","author":"Novaes","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0475","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.1780350403","article-title":"Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate","volume":"35","author":"Sperling","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0480","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.4049\/jimmunol.171.8.4392","article-title":"TNF-alpha induces phosphorylation of p47(phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor","volume":"171","author":"Dewas","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0485","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jcp.1041540305","article-title":"Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta","volume":"154","author":"Fujishima","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0490","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2007-05-087833","article-title":"The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1","volume":"111","author":"Cross","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0495","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.V76.6.1233.1233","article-title":"Activation mechanisms of adherent human neutrophils","volume":"76","author":"Ginis","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0500","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor \u03b1 blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0505","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2009.122655","article-title":"IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy","volume":"69","author":"Verri","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.06.006_bb0510","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3083.2011.02503.x","article-title":"Neutrophils of rheumatoid arthritis patients on anti-TNF-\u03b1 therapy and in disease remission present reduced adhesive functions in association with decreased circulating neutrophil-attractant chemokine levels","volume":"73","author":"Dominical","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0515","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.2006.061507","article-title":"Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis","volume":"66","author":"Wittkowski","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.06.006_bb0520","first-page":"232","article-title":"Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis","volume":"30","author":"den Broeder","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0525","doi-asserted-by":"crossref","first-page":"174855","DOI":"10.1182\/blood-2007-01-067918","article-title":"Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils","volume":"110","author":"Chalaris","year":"2007","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.autrev.2018.06.006_bb0530","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12026-014-8590-4","article-title":"Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature","volume":"61","author":"Shovman","year":"2015","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.autrev.2018.06.006_bb0535","first-page":"541","article-title":"Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials","volume":"56","author":"Moots","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.006_bb0540","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/rheumatology\/keu035","article-title":"Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo","volume":"53","author":"Wright","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2018.06.006_bb0545","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/eci.12799","article-title":"Effects of tocilizumab on neutrophil function and kinetics","volume":"47","author":"Lok","year":"2017","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.autrev.2018.06.006_bb0550","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12026-015-8770-x","article-title":"Disentangling the effects of tocilizumab on neutrophil survival and function","volume":"64","author":"Gaber","year":"2016","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.autrev.2018.06.006_bb0555","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Semin. Hematol."},{"issue":"8","key":"10.1016\/j.autrev.2018.06.006_bb0560","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/art.30427","article-title":"Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections","volume":"63","author":"Tesfa","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.autrev.2018.06.006_bb0565","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12032-008-9049-z","article-title":"Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis","volume":"25","author":"Tesfa","year":"2008","journal-title":"Med. Oncol."},{"key":"10.1016\/j.autrev.2018.06.006_bb0570","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0575","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/art.34329","article-title":"The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-\u03b3 and interleukin-17 production by human CD4+ T cells","volume":"64","author":"Maeshima","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0580","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0585","first-page":"S193","article-title":"Reversibility of pharmacodynamic effects after short-and long-term treatment with tofacitinib in patients with rheumatoid arthritis","volume":"65","author":"Genovese","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0590","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","article-title":"Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial","volume":"381","author":"Burmester","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.06.006_bb0595","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0600","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/art.38779","article-title":"Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis","volume":"66","author":"Cohen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0605","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cei.12970","article-title":"Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production","volume":"189","author":"Mitchell","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0610","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00923346","article-title":"Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids","volume":"15","author":"Ahmadzadeh","year":"1991","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2018.06.006_bb0615","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0952-3278(97)90535-4","article-title":"Increased serum leukotriene B4 level in the active stage of rheumatoid arthritis in children","volume":"56","author":"G\u00fcrsel","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.autrev.2018.06.006_bb0620","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20052371","article-title":"Neutrophil-derived leukotriene B4 is required for inflammatory arthritis","volume":"203","author":"Chen","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0625","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.4049\/jimmunol.176.10.6254","article-title":"Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice","volume":"176","author":"Shao","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0630","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20052349","article-title":"A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis","volume":"203","author":"Kim","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0635","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1073\/pnas.92.2.517","article-title":"Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis","volume":"92","author":"Griffiths","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.06.006_bb0640","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(00)00518-5","article-title":"Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice","volume":"402","author":"Kuwabara","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0645","first-page":"1537","article-title":"Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis","volume":"19","author":"Weinblatt","year":"1992","journal-title":"J Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2018.06.006_bb0650","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199500292-00005","article-title":"Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers","volume":"29","author":"Awni","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.autrev.2018.06.006_bb0655","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/tx0341409","article-title":"In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity","volume":"17","author":"Joshi","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0660","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.110.166967","article-title":"Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain","volume":"334","author":"Masferrer","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2018.06.006_bb0665","article-title":"5-Lipoxygenase inhibitors attenuate TNF-\u03b1-induced inflammation in human synovial fibroblasts","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.06.006_bb0670","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.toxicon.2013.02.009","article-title":"Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease","volume":"69","author":"Uberti","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.autrev.2018.06.006_bb0675","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5114\/reum.2016.62469","article-title":"Esculetin reduces leukotriene B4 level in plasma of rats with adjuvant-induced arthritis","volume":"54","author":"Rzodkiewicz","year":"2016","journal-title":"Reumatologia"},{"key":"10.1016\/j.autrev.2018.06.006_bb0680","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2010.01.006","article-title":"Genetic variation at the CCR5\/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis","volume":"50","author":"Soto-S\u00e1nchez","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2018.06.006_bb0685","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1084\/jem.186.1.131","article-title":"An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model","volume":"186","author":"Gong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0690","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.172.2.890","article-title":"Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells","volume":"172","author":"Br\u00fchl","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0695","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.181.11.8053","article-title":"Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases","volume":"181","author":"Hartl","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0700","first-page":"641","article-title":"Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity","volume":"110","author":"Stankovic","year":"2009","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.autrev.2018.06.006_bb0705","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0710","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0715","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: an update","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0720","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/art.23597","article-title":"CXCR2-specific chemokines mediate leukotriene B 4 \u2013dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis","volume":"58","author":"Grespan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0725","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.bjp.0707462","article-title":"Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats","volume":"153","author":"Barsante","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0730","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/art.23622","article-title":"The chemokine receptors CXCR1\/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature","volume":"58","author":"Coelho","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.006_bb0735","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2009.12.025","article-title":"Pharmacological targeting reveals distinct roles for CXCR2\/CXCR1 and CCR2 in a mouse model of arthritis","volume":"391","author":"Min","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2018.06.006_bb0740","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.20140995","article-title":"IFN-\u03bb resolves inflammation via suppression of neutrophil infiltration and IL-1\u03b2 production","volume":"212","author":"Blazek","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0745","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0750","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0755","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.06.006_bb0760","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/emmm.201100142","article-title":"IL-28A (IFN-\u03bb2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease","volume":"3","author":"Koltsida","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0765","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2007.03441.x","article-title":"The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders","volume":"149","author":"Barksby","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0770","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.06.006_bb0775","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0780","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.173.1.145","article-title":"A novel therapy of murine collagen-induced arthritis with soluble T1\/ST2","volume":"173","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0785","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1073\/pnas.0712116105","article-title":"IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice","volume":"105","author":"Verri","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.06.006_bb0790","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2018.06.006_bb0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002934","article-title":"Citrullination of histone H3 interferes with HP1-mediated transcriptional repression","volume":"8","author":"Sharma","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2018.06.006_bb0800","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501257","article-title":"Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response","volume":"2","author":"Ghari","year":"2016","journal-title":"Sci Adv"},{"key":"10.1016\/j.autrev.2018.06.006_bb0805","doi-asserted-by":"crossref","first-page":"26430","DOI":"10.1038\/srep26430","article-title":"Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses","volume":"6","author":"Kawalkowska","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.06.006_bb0810","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1189\/jlb.3A0314-142RR","article-title":"Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings","volume":"97","author":"Jang","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0815","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1038\/srep13041","article-title":"Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model","volume":"5","author":"Seri","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.06.006_bb0820","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2018.06.006_bb0825","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12891-016-1055-2","article-title":"Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice","volume":"17","author":"Suzuki","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2018.06.006_bb0830","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4049\/jimmunol.180.3.1895","article-title":"Histone deimination as a response to inflammatory stimuli in neutrophils","volume":"180","author":"Neeli","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0835","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2018.06.006_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2018.06.006_bb0845","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cei.12932","article-title":"Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis","volume":"188","author":"Willis","year":"2017","journal-title":"Clin Exp Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:12:57Z","timestamp":1761599577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":169,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1568997218302167"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}